Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
ArsenalBio raises $325M, pivots away from former lead asset
Arsenal Biosciences has added $325 million in ammunition with big-name backers like Regeneron joining the artillery.
Gabrielle Masson
Sep 4, 2024 8:00am
Precigen laying off staff to eke out cash for approval filing
Aug 7, 2024 5:46am
Galapagos pauses CAR-T cell therapy trial over Parkinsonism case
Aug 2, 2024 8:49am
In first, autoimmune patients respond to allogeneic CAR-T cells
Jul 17, 2024 3:26pm
Caribou cuts NK program, lays off 12% to fund CAR-T trials
Jul 17, 2024 5:41am
Cartesian claims autoimmune CAR-T win after changing endpoint
Jul 2, 2024 7:56am